JAN 30, 2017 07:22 PM PST

Flu Shot For Fido

WRITTEN BY: Kara Marker

You’re not the only one who needs to head to the clinic this flu season; your dog might need to pay a visit as well! Yes, dogs can fall victim to the influenza virus just like humans, pigs, birds, and other animals.

There are specific strains that exist among dogs, but they could pass to humans in the future, experts say. To ward off a potentially dangerous “dog flu,” scientists from the University of Rochester introduce a new type of live-attenuated flu vaccine.

It's that dreaded time of year -- flu season. And we humans aren't the only ones feeling the pain. Dogs can get the flu, too. Scientists have developed, for the first time, two new vaccines for canine influenza. Source: University of Rochester School of Medicine and Dentistry

A live-attenuated vaccine contains a weakened virus that, while still alive, triggers an immune response without actually causing illness. On the other hand, inactivated vaccines contain no live virus, only pieces of it that trigger a response. Historically, most live-attenuated vaccines have been the measles/mumps/rubella combined vaccine, chickenpox vaccine, and human influenza vaccine. Polio and hepatitis A are prevented with an inactivated vaccine.

Two new studies, led by scientist Luis Martinez-Sobrido, PhD, resulted in two of the first-ever live-attenuated vaccines for canine influenza, specifically for a strain called H3N8. Veterinarians have used inactivated vaccines for canine flu in the past, but the recent study results suggest that the live-attenuated vaccines are more effective and still very safe. Currently, the H3N8 strain is circulating in dogs in the United States.

Both studies used a genetic engineering technique called reverse genetics, a relatively new approach that, as its name suggests, works in the opposite direction of what many scientists would call “traditional” genetics. Instead of starting with a mutant phenotype and working toward identifying its DNA and protein sequence, a reverse genetics approach begins with recombinant DNA and works backward to identify a mutant phenotype.

The first of Martinez-Sobrido’s studies involved developing a live-attenuated vaccine that solely multiplied in the nose instead of in the lungs. This method was intended to “stop the virus in its tracks” once it made its first stop at the nose, allowing the immune system to wipe out the infection before it traveled to the rest of the body.

The second study removed an integral piece of the H3N8 canine influenza virus to obtain the desired effect of an immune response without the detrimental impact of an actual illness. The protein is called NS1, and past research led scientists to believe that separating it from the H3N8 strain would have this effect.

Both of the studies produced a vaccine candidate that proved to be safe and more effective than existing H3N8 vaccines, which researchers were able to show via tests in mice and in canine tracheal cells. As the research progresses, Martinez-Sobrido plans on beginning clinical trial with dogs, hoping that some day soon the new live-attenuated vaccine for this troublesome strain of canine influenza might be used on a larger level, starting with preventing the spread of disease in shelters and kennels.

The two studies were published in the Journal of Virology and the journal Virology.

Sources: BIO Ventures for Global Health, HistoryofVaccines.org, An Introduction to Genetic Analysis, 7th edition, University of Rochester Medical Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 18, 2018
Immunology
JUL 18, 2018
Immunotherapy Increases Survival of Melanoma Brain Metastases Patients
Use of Checkpoint Blockade Immunotherapy increases survival rates in Melanoma Brain Metastases patients, with a 4-year survival rate increase from 11.1% to 28.1%...
JUL 23, 2018
Immunology
JUL 23, 2018
Obesity Associated Inflammation Leads to Chronic Health Issues
Inflammation caused by harmful oxidized lipids increases in individuals with obesity and may contribute to chronic disease development....
AUG 07, 2018
Immunology
AUG 07, 2018
Age, Sex, Genetics and the Immune Response
Your age, sex, and genetics all play a role in the intensity of your humoral immune response....
OCT 08, 2018
Immunology
OCT 08, 2018
Natural Killer Cells to Aid in Cancer Therapy
Researchers utilize nanoparticles to stimulate NK cells that induce tumor cells to express PDL1, a protein involved in immune response messaging...
NOV 07, 2018
Immunology
NOV 07, 2018
Is Your Brain Asking for High Blood Pressure?
Study finds that the brain is sending signals to the bone marrow to increase blood pressure....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
Loading Comments...